Biomarkers

uMethod Health announced collaboration with Linus Health

uMethod Health, a pioneer in personalized cognitive care planning, has announced that it is collaborating with Linus Health, a digital health company enabling early detection of cognitive impairment, Alzheimer’s and other dementias, to create a more efficient and effective approach to brain health. The collaboration provides clinicians with an integrated solution for earlier detection of cognitive impairment plus care planning.

With the increasing prevalence of cognitive impairment, including Alzheimer’s and other dementias, there is a critical need for innovative solutions that bridge the gap between assessment, diagnosis, and actionable care. The combined solution simplifies the complexities of clinical workflows, offering precise insights for healthcare providers to deliver more effective care across their patient populations.

Closing Care Gaps with Advanced Technologies

The collaboration between uMethod Health and Linus Health empowers clinicians with:

  • Comprehensive cognitive assessments: Linus Health’s state-of-the-art digital health platform offers advanced cognitive assessments that leverage artificial intelligence to provide accurate and timely evaluations of memory and executive function.
  • Personalized care planning: uMethod Health’s innovative platform creates individualized care plans based on a patient’s unique cognitive profile, biomarkers, and medical history, ensuring tailored interventions and treatments.
  • Streamlined workflows: The combined strength of both platforms seamlessly guides clinicians from assessment to care planning, reducing administrative burdens and enhancing clinical efficiency.

Empowering Patients and Clinics

Both uMethod Health and Linus Health are committed to equipping clinicians and patients with the tools they need to navigate complex cognitive care with the integrated solution, which offers:

  • Enhanced patient engagement: Patients gain access to clear, personalized care plans that empower them to take an active role in their cognitive health.
  • Help improve clinical outcomes: Clinicians benefit from precise, data-driven insights that support early diagnosis and effective intervention.
  • Greater accessibility: The partnership offers cutting-edge cognitive care solutions to a broad range of patients and healthcare providers, regardless of their geographic location.

“By combining Linus Health’s advanced cognitive assessment capabilities with uMethod’s personalized care planning, we can help identify individuals in need earlier and significantly enhance the management of their cognitive disorders–ultimately improving patient outcomes,” said David Bates, PhD, Linus Health CEO and co-founder.

Vik Chandra, CEO of uMethod Health, said: “This partnership represents a significant step forward in cognitive care. Together, uMethod and Linus Health are simplifying the complexities of cognitive care workflows and providing clinicians with the tools they need for informed, precise decisions that benefit ALL their patients.”

Explore AITechPark for the latest advancements in AI, IOT, Cybersecurity, AITech News, and insightful updates from industry experts!

Related posts

Mainz Biomed strategically Partners with Ärztliches Labor Dr. Buhlmann

GlobeNewswire

IMVARIA enters into Know-how Agreement with Mayo Clinic

Business Wire

Ellipsis Health to sponsor the APEC Summit

PR Newswire